King's College London

Research portal

Space motion sickness: A common neurovestibular dysfunction in microgravity

Research output: Contribution to journalReview article

Standard

Space motion sickness: A common neurovestibular dysfunction in microgravity. / Russomano, Thais; S G da Rosa, Michele; dos Santos, Marlise A.

In: Neurology India, Vol. 67, No. 8, 24.05.2019, p. S214-S218.

Research output: Contribution to journalReview article

Harvard

Russomano, T, S G da Rosa, M & dos Santos, MA 2019, 'Space motion sickness: A common neurovestibular dysfunction in microgravity', Neurology India, vol. 67, no. 8, pp. S214-S218. https://doi.org/10.4103/0028-3886.259127

APA

Russomano, T., S G da Rosa, M., & dos Santos, M. A. (2019). Space motion sickness: A common neurovestibular dysfunction in microgravity. Neurology India, 67(8), S214-S218. https://doi.org/10.4103/0028-3886.259127

Vancouver

Russomano T, S G da Rosa M, dos Santos MA. Space motion sickness: A common neurovestibular dysfunction in microgravity. Neurology India. 2019 May 24;67(8):S214-S218. https://doi.org/10.4103/0028-3886.259127

Author

Russomano, Thais ; S G da Rosa, Michele ; dos Santos, Marlise A. / Space motion sickness: A common neurovestibular dysfunction in microgravity. In: Neurology India. 2019 ; Vol. 67, No. 8. pp. S214-S218.

Bibtex Download

@article{a4bae4134b174ad2b14cc751d6bbd3e5,
title = "Space motion sickness: A common neurovestibular dysfunction in microgravity",
abstract = "This article presents a review of the current findings related to neurovestibular physiology, aetiology, and proposed theories on space motion sickness (SMS) during acute and sustained exposure to microgravity. The review discusses the available treatment options including medication and nonpharmacological countermeasure methods that help to prevent the development of SMS in weightlessness. Ground-based simulations using virtual reality, flight simulations, and Barany's chairs can be applied to study SMS and demonstrate its signs and symptoms to space crew members. Space motion sickness has been observed in approximately 70% of astronauts within the first 72 h in microgravity, having in general an instantaneous onset of signs and symptoms. Stomach discomfort, nausea, vomiting, pallor, cold sweating, salivation, tachypnoea, belching, fatigue, drowsiness, and stress hormone release have been documented. This can have detrimental effects on the well-being of astronauts in the initial phase of a space mission. Mental and physical performance may be affected, jeopardizing operational procedures and mission safety.",
keywords = "Microgravity, neurology, space motion sickness, space neurovestibular physiology",
author = "Thais Russomano and {S G da Rosa}, Michele and {dos Santos}, {Marlise A.}",
year = "2019",
month = may,
day = "24",
doi = "10.4103/0028-3886.259127",
language = "English",
volume = "67",
pages = "S214--S218",
journal = "Neurology India",
issn = "0028-3886",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "8",

}

RIS (suitable for import to EndNote) Download

TY - JOUR

T1 - Space motion sickness: A common neurovestibular dysfunction in microgravity

AU - Russomano, Thais

AU - S G da Rosa, Michele

AU - dos Santos, Marlise A.

PY - 2019/5/24

Y1 - 2019/5/24

N2 - This article presents a review of the current findings related to neurovestibular physiology, aetiology, and proposed theories on space motion sickness (SMS) during acute and sustained exposure to microgravity. The review discusses the available treatment options including medication and nonpharmacological countermeasure methods that help to prevent the development of SMS in weightlessness. Ground-based simulations using virtual reality, flight simulations, and Barany's chairs can be applied to study SMS and demonstrate its signs and symptoms to space crew members. Space motion sickness has been observed in approximately 70% of astronauts within the first 72 h in microgravity, having in general an instantaneous onset of signs and symptoms. Stomach discomfort, nausea, vomiting, pallor, cold sweating, salivation, tachypnoea, belching, fatigue, drowsiness, and stress hormone release have been documented. This can have detrimental effects on the well-being of astronauts in the initial phase of a space mission. Mental and physical performance may be affected, jeopardizing operational procedures and mission safety.

AB - This article presents a review of the current findings related to neurovestibular physiology, aetiology, and proposed theories on space motion sickness (SMS) during acute and sustained exposure to microgravity. The review discusses the available treatment options including medication and nonpharmacological countermeasure methods that help to prevent the development of SMS in weightlessness. Ground-based simulations using virtual reality, flight simulations, and Barany's chairs can be applied to study SMS and demonstrate its signs and symptoms to space crew members. Space motion sickness has been observed in approximately 70% of astronauts within the first 72 h in microgravity, having in general an instantaneous onset of signs and symptoms. Stomach discomfort, nausea, vomiting, pallor, cold sweating, salivation, tachypnoea, belching, fatigue, drowsiness, and stress hormone release have been documented. This can have detrimental effects on the well-being of astronauts in the initial phase of a space mission. Mental and physical performance may be affected, jeopardizing operational procedures and mission safety.

KW - Microgravity

KW - neurology

KW - space motion sickness

KW - space neurovestibular physiology

UR - http://www.scopus.com/inward/record.url?scp=85066807667&partnerID=8YFLogxK

U2 - 10.4103/0028-3886.259127

DO - 10.4103/0028-3886.259127

M3 - Review article

VL - 67

SP - S214-S218

JO - Neurology India

JF - Neurology India

SN - 0028-3886

IS - 8

ER -

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454